Petersenn S et al (2017) [Diagnostics and treatment of acromegaly: necessity for targeted monitoring of comorbidities]. Internist (Berl) 58(11):1171–1182
Article CAS PubMed Google Scholar
Fleseriu M et al (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804–826
Article CAS PubMed Google Scholar
Melmed S, Pituitary-Tumor Endocrinopathies (2020) N Engl J Med 382(10):937–950
Article CAS PubMed Google Scholar
Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667–674
Article CAS PubMed Google Scholar
Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159(2):89–95
Article CAS PubMed Google Scholar
Dekkers OM et al (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61–67
Article CAS PubMed Google Scholar
Chen CJ et al (2017) Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien) 159(11):2193–2207
Mortini P et al (2018) Microsurgical therapy of pituitary adenomas. Endocrine 59(1):72–81
Article CAS PubMed Google Scholar
Melmed S et al (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552–561
Article PubMed PubMed Central Google Scholar
Hong S et al (2022) Acromegaly and cardiovascular outcomes: a cohort study. Eur Heart J 43(15):1491–1499
Dal J et al (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181–190
Article CAS PubMed Google Scholar
Lesen E et al (2017) Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur J Endocrinol 176(2):203–212
Article CAS PubMed Google Scholar
Colao A et al (2011) Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. Eur J Endocrinol 165(5):713–721
Article CAS PubMed Google Scholar
Giustina A et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab, 105(4)
Berg C et al (2010) Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J Clin Endocrinol Metab 95(8):3648–3656
Article CAS PubMed Google Scholar
Schofl C et al (2017) Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary 20(6):635–642
Mercado M et al (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438–4446
Article CAS PubMed Google Scholar
Ritvonen E et al (2016) Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer 23(6):469–480
Article CAS PubMed Google Scholar
Maione L et al (2017) Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176(5):645–655
Article CAS PubMed Google Scholar
Esposito D et al (2018) Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur J Endocrinol 178(5):459–469
Article CAS PubMed Google Scholar
ICD-10-GM Version (2023) Systematisches Verzeichnis, Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, Stand: 16.09.2022, D.I.f.M.D.u. Information, Editor. 2020, Bundesinstitut für Arzneimittel und Medizinprodukte BfArM) im Auftrag des Bundesministeriums für Gesundheit (BMG) unter Beteiligung der Arbeitsgruppe ICD des Kuratoriums für Fragen der Klassifikation im Gesundheitswesen (KKG): Köln
(WHO) (2019) W.H.O., International Statistical Classification of Diseases and Related Health Problems 10th Revision
Schweizerische Operationsklassifikation (CHOP), Systematisches Verzeichnis - Version 2023, E.D.d.I. EDI, editor. (2022) Bundesamt für Statistik BFS: Neuchâtel
Katznelson L et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Article CAS PubMed Google Scholar
Bonadonna S et al (2005) Diagnosis and treatment of acromegaly and its complications: consensus guidelines. J Endocrinol Invest 28(11 Suppl International):43–47
Gadelha MR et al (2019) Systemic complications of Acromegaly and the impact of the Current Treatment Landscape: an update. Endocr Rev 40(1):268–332
Tampourlou M et al (2018) Mortality in patients with non-functioning pituitary adenoma. Pituitary 21(2):203–207
Article PubMed PubMed Central Google Scholar
Olsson DS et al (2015) Excess mortality in women and young adults with nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study. J Clin Endocrinol Metab 100(7):2651–2658
Article CAS PubMed Google Scholar
Chanson P et al (2015) Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76(3):239–247
Molitch ME (2017) Diagnosis and treatment of Pituitary adenomas: a review. JAMA 317(5):516–524
Lucas JW et al (2016) Congress of Neurological Surgeons Systematic Review and evidence-based Guideline on Primary Management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E533–E535
Lindholm J et al (2006) Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol (Oxf) 65(1):51–58
Article CAS PubMed Google Scholar
Jasim S et al (2017) Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine 56(1):33–42
留言 (0)